QTTB Q4 2024 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$73M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0+100.0% YoY

Gross Profit

$0

Operating Income

-$15M

Net Income

-$14M

EPS (Diluted)

$-1.16

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$92M

Total Liabilities

$87M

Stockholders' Equity

$6M

Cash & Equivalents

$78M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	-$15M	+100.0%
Gross Profit	$0	-$15M	+100.0%
Operating Income	-$15M	-$26M	+43.7%
Net Income	-$14M	-$27M	+47.6%